tiprankstipranks
Advertisement
Advertisement

EBR Systems Reports Contained Data Breach With Limited Impact on Operations

Story Highlights
  • EBR Systems reported a contained data breach involving unauthorized access to its network without disrupting business operations.
  • A small amount of patient health data may have been exposed, but insurance is expected to cover incident costs as the review continues.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EBR Systems Reports Contained Data Breach With Limited Impact on Operations

Claim 30% Off TipRanks

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has provided an announcement.

EBR Systems, Inc., developer of the world’s only wireless cardiac pacing device for heart failure, has disclosed a data security breach involving unauthorized access to information on its network. The incident, first detected in February, was contained without disrupting operations, and the company has engaged forensic specialists while maintaining that it does not expect any material operational impact.

The company says a small amount of patients’ personal health information may have been accessed and is posting notices online to alert potentially affected individuals. EBR notes that cyber security insurance is expected to cover the costs of the incident, including external experts, and it plans to provide further updates on its website as the review continues.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.47 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

EBR Systems, Inc. is a Silicon Valley-based medical technology company focused on treating cardiac rhythm disease through wireless cardiac pacing solutions. Its proprietary WiSE technology delivers endocardial stimulation to the left ventricle without traditional pacing leads, targeting heart failure patients requiring Cardiac Resynchronisation Therapy and with potential future applications in bradycardia and other indications.

Average Trading Volume: 528,123

Technical Sentiment Signal: Sell

Current Market Cap: A$301.7M

For a thorough assessment of EBR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1